Showing results (181-190 of 187) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
International Urology and Nephrology|May 1, 2025
Nephrotoxicity of CAR-T therapy in patients with relapsed and refractory multiple myelomaZihan Chen, Yegan Chen, Jiaying Liu, et al.Nature Communications|April 20, 2024
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trialMing Shi, Jiaojiao Wang, Hongming Huang, et al.Haematologica|May 26, 2018
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosisJianlin Qiao, Xiaoqing Wu, Qi Luo, et al.American Journal of Hematology|February 18, 2022
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemiaMing Shi, Li Li, Shiyuan Wang, et al.Clinical and Experimental Medicine|November 1, 2023
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapyHai Cheng, Shengwei Ji, Jiaojiao Wang, et al.Blood|June 29, 2022
Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formationXiamin Wang, Guangyu Wei, Yangyang Ding, et al.Cancer Medicine|July 2, 2020
Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphomaWei Sang, Ming Shi, Jingjing Yang, et al.Pageof 19